5 exciting small caps I've added to my watch list

TPG Telecom Ltd (ASX:TPM) wasn't always a blue-chip share. Just 10 years ago it was a small cap about the size of Afterpay Holdings Ltd (ASX:AFY). Could these five shares follow the same path?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Telecommunication giant TPG Telecom Ltd (ASX: TPM) wasn't always a blue-chip share. In fact, just 10 years ago the whole company had a market value of just $238 million. That's a far cry from the $11 billion market capitalisation it had last year prior to the sell-off in its shares.

Lucky investors which have held its shares for 10 years have seen an average annual return of 29%, even after accounting for the halving of its share price in the last six months. This means a $10,000 investment in TPG Telecom would be worth almost $130,000 today.

I believe this demonstrates the power of buy-and-hold investing and the potential reward investors can receive if they find a future blue-chip share when it is still a fledgling small-cap.

Whilst achieving this level of return might be wishful thinking, here are five promising small-caps which I think are worth adding to your watch list today:

Afterpay Holdings Ltd (ASX: AFY)

This payments company currently provides 2,100 retailers with the ability to offer an interest-free buy now, pay later service online and in-store. Afterpay bears the default risk in exchange for a small commission on the transaction. Two weeks ago the company reported that it processed over $100 million in underlying sales during the December quarter. This was a massive 146% increase on the prior quarter. Afterpay is definitely a company to keep a close eye on in my opinion.

Bionomics Ltd (ASX: BNO)

Although this biopharmaceutical company had a couple of disappointing years with little progress being made it appears to be on the right path now. So much so I believe Bionomics' development pipeline has the potential to transform it into a much bigger player in the industry. The company's anxiety drug BNC210 has shown a lot of promise in recent trials. With the market expected to be worth up to US$18 billion a year by 2020, Bionomics could be positioned for explosive long-term growth.

Collins Foods Ltd (ASX: CKF)

Collins Food operates KFC restaurants in Queensland, Western Australia, and the Northern Territory. Whilst its domestic operations are reasonably strong, the big attraction in my opinion is its European expansion. Last year the company acquired 11 KFC restaurants in Germany. As KFC Germany plans to rapidly expand its store network, I believe Collins Food has arrived in the country at an opportune time.

Eden Innovations Ltd (ASX: EDE)

This clean energy company could have an extremely bright future thanks to its EdenCrete carbon nanotube enriched liquid concrete admixture. Trials in the United States have shown that EdenCrete 'enriched concrete' on a busy highway vastly outperformed regular concrete mix. Trials are now underway to test its use for applications including ready mix concrete, low shrinkage concrete for dams, and pre-cast applications.

Medical Developments International Ltd (ASX: MVP)

MDI is the company behind the Penthrox pain management product also known as the green whistle. Last year the company expanded its international presence significantly by gaining approval for its sale in countless countries across the world. Never one to rest on its laurels, the company has recently commenced with a clinical program to expand its use into minor surgical procedures. Management estimates this market to be worth around $2 billion a year.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »